Capitalize on Denmark's R&D ecosystem, public reimbursement, biologics, personalized medicine, generics and rising chronic disease demandDublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- "Denmark ...

An analysis estimates Trump increased his stock holdings from $1.7 million in 2024 to up to $56.2 million last year.

A brief overview of the careers, tenures and major accomplishments of the CEOs of the top 10 global pharma and biopharma ...

The gifts and payments that doctors receive from drugmakers increased inappropriate prescribing, likely leading to rising ...

Global Pharmaceutical Sterility Testing Market size is expected to be worth around US$ 5.4 Billion by 2034 from US$ 1.8 ...

The pharmaceutical industry has shifted its focus from the initial novelty of artificial intelligence toward a critical ...

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the global healthcare sector, continues to capture investor ...

Target high-growth electronic-grade CSI for EV batteries, secure multi-year reshoring contracts, and preserve stable pharmaceutical and agrochemical demand.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Novo Nordisk A/S (NYSE: NVO), a Danish healthcare giant, has long been a stalwart in the pharmaceutical industry, particularly in diabetes and obesity care. With a market capitalization of $171.36 ...

On October 14, 2026, the European Federation of Pharmaceutical Industries and Associations (EFPIA) held a press event for ...

Recursion Pharma launches a $200M equity offering and reports a Sanofi milestone but is rated a Hold on limited near-term ...